TDSPharm Co Ltd (464280)

Currency in KRW
9,400.00
+10.00(+0.11%)
Closed·
464280 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
9,260.009,520.00
52 wk Range
8,330.0014,830.00
Key Statistics
Bid/Ask
9,400.00 / 9,410.00
Prev. Close
9,390
Open
9,490
Day's Range
9,260-9,520
52 wk Range
8,330-14,830
Volume
9.92K
Average Volume (3m)
49.84K
1-Year Change
-32.4227%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
464280 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Prominent player in the Pharmaceuticals industry

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Buy
Moving Averages
Neutral

TDSPharm Co Ltd Company Profile

Tdspharm Co., Ltd. researches, develops, and produces pharmaceuticals and cosmetics in South Korea and internationally. It offers general medicines, prescription drugs, and non-medicinal products. The company was founded in 2002 and is based in Seongnam-si, South Korea.

Compare 464280 to Peers and Sector

Metrics to compare
464280
Peers
Sector
Relationship
P/E Ratio
15.8x11.3x−0.6x
PEG Ratio
−0.380.010.00
Price/Book
1.3x0.8x2.6x
Price / LTM Sales
2.1x0.7x3.4x
Upside (Analyst Target)
-20.1%41.1%
Fair Value Upside
Unlock13.4%5.3%Unlock
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
Nov 14, 2025
EPS / Forecast
276.00 / --
Revenue / Forecast
8.08B / --
EPS Revisions
Last 90 days

464280 Income Statement

FAQ

What Is the TDSPharm (464280) Stock Price Today?

The TDSPharm stock price today is 9,400.00

What Stock Exchange Does TDSPharm Trade On?

TDSPharm is listed and trades on the KOSDAQ stock exchange.

What Is the Stock Symbol for TDSPharm?

The stock symbol for TDSPharm is "464280."

What Is the TDSPharm Market Cap?

As of today, TDSPharm market cap is 51.98B.

What Is TDSPharm's Earnings Per Share (TTM)?

The TDSPharm EPS (TTM) is 620.38.

When Is the Next TDSPharm Earnings Date?

TDSPharm will release its next earnings report on Mar 22, 2026.

From a Technical Analysis Perspective, Is 464280 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has TDSPharm Stock Split?

TDSPharm has split 0 times.

What is the current trading status of TDSPharm (464280)?

As of Jan 17, 2026, TDSPharm (464280) is trading at a price of 9,400.00, with a previous close of 9,390.00. The stock has fluctuated within a day range of 9,260.00 to 9,520.00, while its 52-week range spans from 8,330.00 to 14,830.00.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.